[go: up one dir, main page]

WO2008154350A3 - Use of tight junction agonists to suppress immune responses - Google Patents

Use of tight junction agonists to suppress immune responses Download PDF

Info

Publication number
WO2008154350A3
WO2008154350A3 PCT/US2008/066057 US2008066057W WO2008154350A3 WO 2008154350 A3 WO2008154350 A3 WO 2008154350A3 US 2008066057 W US2008066057 W US 2008066057W WO 2008154350 A3 WO2008154350 A3 WO 2008154350A3
Authority
WO
WIPO (PCT)
Prior art keywords
tight junction
immune responses
suppress immune
agonists
junction agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/066057
Other languages
French (fr)
Other versions
WO2008154350A2 (en
Inventor
Amir Tamiz
Niranjan Pandey
Blake Paterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
9 Meters Biopharma Inc
Original Assignee
Alba Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alba Therapeutics Corp filed Critical Alba Therapeutics Corp
Publication of WO2008154350A2 publication Critical patent/WO2008154350A2/en
Publication of WO2008154350A3 publication Critical patent/WO2008154350A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention provides materials and methods to suppress an excessive or undesired immune response. In some embodiments, agonists of biological pathways responsible for opening and closing tight junctions (e.g., tight junction agonists) are used in compositions with antigens to suppress an immune response to the antigen.
PCT/US2008/066057 2007-06-08 2008-06-06 Use of tight junction agonists to suppress immune responses Ceased WO2008154350A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94297807P 2007-06-08 2007-06-08
US60/942,978 2007-06-08

Publications (2)

Publication Number Publication Date
WO2008154350A2 WO2008154350A2 (en) 2008-12-18
WO2008154350A3 true WO2008154350A3 (en) 2009-02-26

Family

ID=40130444

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/066057 Ceased WO2008154350A2 (en) 2007-06-08 2008-06-06 Use of tight junction agonists to suppress immune responses

Country Status (1)

Country Link
WO (1) WO2008154350A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338297A (en) * 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US20050119171A1 (en) * 2001-08-10 2005-06-02 Genset S.A. Human cdnas and proteins and uses thereof
US20060165722A1 (en) * 2005-01-14 2006-07-27 University Of Maryland, Baltimore Peptides for delivery of mucosal vaccines
US20060276399A1 (en) * 1998-08-03 2006-12-07 University Of Maryland - Baltimore Peptide antagonists of zonulin and methods for use of the same
US20070122423A1 (en) * 2001-08-17 2007-05-31 Glaxosmithkline Biologicals Sa Derp1 and proderp1 allergen derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338297A (en) * 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US20060276399A1 (en) * 1998-08-03 2006-12-07 University Of Maryland - Baltimore Peptide antagonists of zonulin and methods for use of the same
US20050119171A1 (en) * 2001-08-10 2005-06-02 Genset S.A. Human cdnas and proteins and uses thereof
US20070122423A1 (en) * 2001-08-17 2007-05-31 Glaxosmithkline Biologicals Sa Derp1 and proderp1 allergen derivatives
US20060165722A1 (en) * 2005-01-14 2006-07-27 University Of Maryland, Baltimore Peptides for delivery of mucosal vaccines

Also Published As

Publication number Publication date
WO2008154350A2 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
WO2007100908A3 (en) Chimeric adenoviral vectors
LTC1971366I2 (en) Human anti-IL-23 antibodies, compositions, methods, and uses
NO20083397L (en) Anti-EphB4 antibodies and methods for their use
WO2010011944A3 (en) Protein screeing methods
WO2007084321A3 (en) Antibodies to ox-2/cd200 and uses thereof
PH12019501796A1 (en) Low ph pharmaceutical composition comprising t cell engaging antibody constructs
WO2011047087A3 (en) Protein detection via nanoreporters
NO20084356L (en) Anti TAT226 antibodies and immunoconjugates
WO2017147542A3 (en) Optimized transglutaminase site-specific antibody conjugation
MX2009013199A (en) Anti-notch1 nrr antibodies and methods using same.
IL204542A (en) Monoclonal antibodies specific for the protofibril form of beta-amyloid protein, compositions, methods and uses pertaining thereto
CU20120095A7 (en) PCSK9 ANTAGONISTS
WO2007133290A3 (en) Anti-ox40l antibodies and methods using same
BRPI0812488A2 (en) HUMANIZED AND CHEMICAL ANTI-BODIES ANTIBODIES MEDIATION OF CANCER CELL, USES OF THE SAME, CONNECTION TESTS, METHODS, COMPOSITIONS AND TEST KIT
WO2006083936A3 (en) Anti-ephb2 antibodies and methods using same
BRPI0821211A2 (en) Humanized cd34 anti-human antibody, the method of preparation and uses thereof.
EP4219560A3 (en) Integrin alpha v beta 8 neutralizing antibody
WO2009134429A3 (en) Methods and compositions for modulating immunological tolerance
WO2011053565A3 (en) Compositions and methods for detecting a tauopathy
WO2009035738A3 (en) Use of antibody secreting cell elispot to assess antibody responses following antigen exposure
NO20083593L (en) Anti-EphrinB2 antibodies and methods for their use
WO2015009740A3 (en) Anti-mucin 1 binding agents and uses thereof
WO2008043000A3 (en) Ehrlicia canis diva (differentiate infected from vaccinated animals)
WO2009070507A3 (en) Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08770290

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08770290

Country of ref document: EP

Kind code of ref document: A2